Edition:
United States

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
4:00pm EDT
Change (% chg)

$0.07 (+5.88%)
Prev Close
$1.19
Open
$1.22
Day's High
$1.28
Day's Low
$1.22
Volume
32,262
Avg. Vol
64,797
52-wk High
$2.05
52-wk Low
$0.75

Chart for

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for .

Overall

Beta: 3.72
Market Cap(Mil.): $21.60
Shares Outstanding(Mil.): 16.96
Dividend: --
Yield (%): --

Financials

  GENE.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.33 -- --
ROI: -68.94 1.96 12.83
ROE: -69.24 1.12 14.95

Earnings vs. Estimates